Slim Fast, Biggest Loser gain lead
Slim Fast and The Biggest Loser diets were identified as among the leading diets by U.S. News & World Report earlier this month. The ranking may reinvigorate sales across the Slim Fast franchise, which dropped to No. 11 across weight control liquids sold through food, drug and mass (excluding Walmart) for the 12 weeks ended Nov. 27 with $4.8 million in sales, according to SymphonyIRI Group. And while not necessarily associated with the Biggest Loser diet, Biggest Loser trainer Bob Harper’s signature diet aid tablet is on the rise with $1 million in sales, ranking No. 10 among diet aids.
The article above is part of the DSN Category Review Series. For the complete Diet/Weight Loss Sell-Through Report, including extensive charts, data and more analysis, click here.
Study: Many don’t inform doctors of smoking habit
WASHINGTON — Approximately 13% of smokers do not disclose their tobacco habit to their healthcare provider, according to a recent survey released by the American Legacy Foundation. And while a majority of smokers did admit their smoking status, only some 25% sought help from their doctors or healthcare providers during their last attempt to quit.
“Healthcare providers play a critical role in reaching smokers with appropriate messages and resources for quitting, especially now that insurance coverage has expanded to include some smoking cessation treatments,” stated Cheryl Healton, Legacy president and CEO. “It becomes a missed public health opportunity if what amounts to more than 6 million smokers in the United States do not talk to doctors and nurses about smoking and quitting.”
To address the void between doctors and all smokers, Legacy has developed a guide for healthcare providers with strategies on how to conduct more meaningful and effective conversations with their patients about smoking and quitting.
Legacy is the national, independent public health foundation that was created in 1999 out of the landmark Master Settlement Agreement between the tobacco industry, 46 state governments and five U.S. territories.
Awareness expected to benefit diabetes, DME
According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition.
The opportunity, though, is in helping to manage the condition. An expected growth in medication therapy management offerings necessary to improve patient compliance and drive down healthcare costs, coupled with the continued advancement in telemedicine infrastructure — the iPodding of diabetes testing supplies — represent the real growth drivers beyond the simple projected increase in need for diabetes-related supplies.
There is a similar growth trajectory associated with the sale of durable medical equipment. Baby boomers, the first of whom celebrated their 65th birthdays last year, are still some 10 to 15 years from needing daily living assistance products themselves. But much of that business is migrating to the drug channel with consumers paying for those items with cash, as opposed to through insurers like Medicare because of a trend toward home health care versus nursing homes and a growing awareness that affordable DME products are available at retail.
The article above is part of the DSN Category Review Series. For the complete DME/Diabetes Buy-In Report, including extensive charts, data and more analysis, click here.